Update on FDA’s Order Removing JUUL Products from US Market.

On June 23, the FDA  denied the authorization to market JUUL products and ordered current products to be taken off the US Market. JUUL was then granted a temporary stay of the order from a federal appeals court. JUUL separately had asked the FDA to stay its own order pending JUUL’s appeal of the decision. The most recent status on this issue is that the FDA has stayed its order, allowing Juul Labs Inc to stay on the U.S. market while the e-cigarette maker appeals the agency’s ban. The FDA commented that there are scientific issues unique to the JUUL application that warrant additional review and that the agency’s stay temporarily suspends the order during the additional review but does not rescind it.